(1) All identifying information regarding individual patients, health care facilities and practitioners reported pursuant to ORS § 432.520 shall be confidential and privileged. Except as required in connection with the administration or enforcement of public health laws or rules, no public health official, employee or agent shall be examined in an administrative or judicial proceeding as to the existence or contents of data collected under the registry system for cancer and benign or borderline tumors of the brain and central nervous system.

(2) All additional information reported in connection with a special study shall be confidential and privileged and shall be used solely for the purposes of the study, as provided by ORS § 413.196. Nothing in this section shall prevent the Oregon Health Authority from publishing statistical compilations relating to morbidity and mortality studies that do not identify individual cases or prevent use of this data by third parties to conduct research as provided by ORS § 432.540 (1). [1995 c.585 § 5; 2003 c.269 § 4; 2009 c.595 § 621; 2017 c.101 § 38]

See note under 432.500.